>
Why Geological Maps Are the Best Investment You've Never Heard Of
High School Student Discovers 1.5 Million Potential New Astronomical Objects...
UK Supreme Court says legal definition of 'woman' excludes trans women, in landmark ruling
Major Problem in Physics Could Be Fixed if The Whole Universe Was Spinning
Kawasaki CORLEO Walks Like a Robot, Rides Like a Bike!
World's Smallest Pacemaker is Made for Newborns, Activated by Light, and Requires No Surgery
Barrel-rotor flying car prototype begins flight testing
Coin-sized nuclear 3V battery with 50-year lifespan enters mass production
BREAKTHROUGH Testing Soon for Starship's Point-to-Point Flights: The Future of Transportation
Molten salt test loop to advance next-gen nuclear reactors
Quantum Teleportation Achieved Over Internet For The First Time
Watch the Jetson Personal Air Vehicle take flight, then order your own
Microneedles extract harmful cells, deliver drugs into chronic wounds
SpaceX Gigabay Will Help Increase Starship Production to Goal of 365 Ships Per Year
As of 8:10am, S&P futures are 2.9% higher, a bounce which started around the time we informed readers that Goldman's head of risk of risk had turned bullish yesterday afternoon; Nasdaq futures are up 2.7%, with all Mag7 names higher with Semis and Cyclicals also outperforming. European and Asian markets are also broadly higher. The VIX is down 10 vols below 40, while Chinese ADRs are mixed. Bond yields have reversed earlier losses and are up 1bp to 4.22% with the USD dropping. Todays' macro data focus is the Small Business Optimism report which saw sentiment tumble to 97.4 from 100.7 the lowest since the Trump election (Hiring Plans also slumped; these tend to have a lagged but positive correlation to NFP).
In premarket trading, Nvidia is leading the Magnificent Seven higher (Nvidia +4%, Amazon +3.3%, Meta +3%, Tesla +3.0%, Alphabet +2.5%, Apple +1.6%, Microsoft little changed). Health insurance stocks are rallying after the Centers for Medicare & Medicaid Services finalized a 5.06% average increase in payments to Medicare Advantage plans from 2025 to 2026, an increase from its earlier projection (Humana +14%, Alignment Healthcare +10%, CVS +8.8%, UnitedHealth +7.2%, Centene +4.9%). Here are some other notable premarket movers:
Agco Corp. (AGCO) rises 2% after Citi upgraded the agricultural equipment company to buy, saying that the company is "favorably positioned given its ~65% exposure to Europe and South America, which we anticipate recovering ahead" of North America.
Blackstone (BX) rises 3% after the private equity firm is upgraded to market outperform from market perform at Citizens.
Chegg (CHGG) falls 2% as JPMorgan downgrades its rating to underweight, saying the education technology company is facing secular headwinds.
CME (CME) rises 2.5% and Charles Schwab (SCHW) gains 3.4% after Morgan Stanley upgrades its ratings across exchange operators and brokers in a hunt for more defensive exposure.
El Pollo Loco (LOCO) rises 10% after receiving an unsolicited, non-binding indication of interest from Biglari Capital Corp.
Eli Lilly & Co (LLY) climbs 2% after Goldman Sachs upgraded the obesity drugmaker to buy, citing a "compelling entry point into the sector's premier topline grower" at current levels.
Levi Strauss (LEVI) jumps 11% after the apparel retailer maintained its full-year outlook in the face of sweeping new US tariffs that are poised to significantly raise costs for multinational apparel companies.
Marvell Technology (MRVL) climbs 4% after Infineon agreed to buy the chip designer's automotive networking business for $2.5 billion. The deal makes sense given the firm's strategic focus on artificial intelligence, analysts say.
Nu Holdings (NU) rises 4% after JPMorgan upgraded the bank to overweight, saying "even in our more conservative estimates we see Nu growing earnings more than 30% in next 3 years, something hard to find."
Teradata Corp. (TDC) rises 4% after Morgan Stanley upgraded the database management company to overweight, saying "we acknowledge the company remains a model in transition with risk of extending sales cycles," but at the current valuation, "we believe this is more than priced in."